← FDA ENFORCEMENT
D-0313-2024Class III
Dr. Reddy's Laboratories, Inc.
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product type
Drug
Status
Ongoing
Report date
2024-02-14
Distribution
Nationwide
Firm state
NJ
Product quantity
14,425 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall
Misprint on tablet
Product description
Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05
Code / lot info
Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →